BCI
SBRA icon

Brinker Capital Investments’s Sabra Healthcare REIT SBRA Stock Holding History

Brinker Capital Investments’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
64,354
+515
+0.8% +$10.2K 0.01% 1028
2026
Q1 		$1.23M Sell
63,839
-13,626
-18% -$268K 0.01% 995
2025
Q4 		$1.47M Sell
77,465
-15,145
-16% -$281K 0.01% 1018
2025
Q3 		$1.73M Buy
92,610
+1,905
+2% +$35.6K 0.01% 918
2025
Q2 		$1.67M Buy
90,705
+9,095
+11% +$161K 0.01% 884
2025
Q1 		$1.43M Sell
81,610
-830
-1% -$14K 0.01% 892
2024
Q4 		$1.43M Sell
82,440
-2,868
-3% -$52.4K 0.01% 862
2024
Q3 		$1.59M Sell
85,308
-1,168
-1% -$19.7K 0.02% 811
2024
Q2 		$1.33M Buy
86,476
+4,112
+5% +$58.8K 0.01% 841
2024
Q1 		$1.22M Buy
82,364
+1,962
+2% +$27.2K 0.01% 892
2023
Q4 		$1.11M Sell
80,402
-2,723
-3% -$38.7K 0.01% 898
2023
Q3 		$1.16M Sell
83,125
-2,243
-3% -$28.7K 0.01% 862
2023
Q2 		$1M Sell
85,368
-300
-0.4% -$3.42K 0.01% 957
2023
Q1 		$985K Buy
85,668
+14,909
+21% +$184K 0.01% 878
2022
Q4 		$880K Buy
70,759
+1,151
+2% +$14.7K 0.02% 774
2022
Q3 		$913K Sell
69,608
-4,649
-6% -$68.7K 0.02% 751
2022
Q2 		$1.04M Buy
74,257
+5,497
+8% +$73.5K 0.02% 728
2022
Q1 		$1.02M Buy
68,760
+13,258
+24% +$181K 0.02% 787
2021
Q4 		$752K Sell
55,502
-2,867
-5% -$40.6K 0.01% 926
2021
Q3 		$1.06M Hold
58,369
– – 0.02% 754
2021
Q2 		$1.06M Buy
58,369
+1,268
+2% +$22.6K 0.01% 808
2021
Q1 		$991K Buy
+57,101
New +$1M 0.01% 708
2020
Q4 		– Sell
-59,281
Closed -$817K – 1171
2020
Q3 		$817K Buy
+59,281
New +$871K 0.01% 751
2020
Q1 		– Sell
-443
Closed -$9K – 668
2019
Q4 		$9K Buy
443
+306
+223% +$6.85K ﹤0.01% 582
2019
Q3 		$3K Hold
137
– – ﹤0.01% 686
2019
Q2 		$3K Hold
137
– – ﹤0.01% 875
2019
Q1 		$3K Hold
137
– – ﹤0.01% 763
2018
Q4 		$2K Hold
137
– – ﹤0.01% 626
2018
Q3 		$3K Hold
137
– – ﹤0.01% 584
2018
Q2 		$3K Buy
+137
New +$2.68K ﹤0.01% 561

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Brinker Capital Investments's SBRA Position: Q2 2026 in Review

Brinker Capital Investments increased its Sabra Healthcare REIT (SBRA) stake by 0.81% in Q2 2026, buying an estimated $10.2K and bringing the position to 64,354 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #1028.

Brinker Capital Investments first reported a position in SBRA in Q2 2018 and has held it in 30 quarters since. The position peaked at $1.73M in Q3 2025. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Brinker Capital Investments held 64,354 shares of Sabra Healthcare REIT worth $1.26M as of Q2 2026.
  • Brinker Capital Investments bought 515 Sabra Healthcare REIT shares in Q2 2026, an estimated $10.2K.
  • Sabra Healthcare REIT made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1028 holding.
  • Brinker Capital Investments first reported a position in Sabra Healthcare REIT in Q2 2018 and has held it in 30 quarters since.
  • Brinker Capital Investments's Sabra Healthcare REIT position peaked at $1.73M in Q3 2025.
  • 466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.